BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 35973530)

  • 41. Prenatal exposure to perfluoroalkyl substances and birth outcomes in a Spanish birth cohort.
    Manzano-Salgado CB; Casas M; Lopez-Espinosa MJ; Ballester F; Iñiguez C; Martinez D; Costa O; Santa-Marina L; Pereda-Pereda E; Schettgen T; Sunyer J; Vrijheid M
    Environ Int; 2017 Nov; 108():278-284. PubMed ID: 28917208
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Association among serum per- and polyfluoroalkyl substances, lipid profile and metabolic syndrome in Czech adults, HBM-EHES survey 2019.
    Puklová V; Čapková N; Fialová A; Vavrouš A; Žejglicová K; Černá M
    Cent Eur J Public Health; 2023 Dec; 31(4):227-234. PubMed ID: 38309699
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Associations between serum concentrations of perfluoroalkyl acids and serum lipid levels in a Chinese population.
    Fu Y; Wang T; Fu Q; Wang P; Lu Y
    Ecotoxicol Environ Saf; 2014 Aug; 106():246-52. PubMed ID: 24863755
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prenatal exposure to 11 perfluoroalkyl substances and fetal growth: A large-scale, prospective birth cohort study.
    Kashino I; Sasaki S; Okada E; Matsuura H; Goudarzi H; Miyashita C; Okada E; Ito YM; Araki A; Kishi R
    Environ Int; 2020 Mar; 136():105355. PubMed ID: 32029284
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Estimation of per- and polyfluoroalkyl substances (PFAS) half-lives in human studies: a systematic review and meta-analysis.
    Rosato I; Bonato T; Fletcher T; Batzella E; Canova C
    Environ Res; 2024 Feb; 242():117743. PubMed ID: 38008199
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Behavioral difficulties in 7-year old children in relation to developmental exposure to perfluorinated alkyl substances.
    Oulhote Y; Steuerwald U; Debes F; Weihe P; Grandjean P
    Environ Int; 2016 Dec; 97():237-245. PubMed ID: 27692925
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Exposure to novel and legacy per- and polyfluoroalkyl substances (PFASs) and associations with type 2 diabetes: A case-control study in East China.
    Han X; Meng L; Zhang G; Li Y; Shi Y; Zhang Q; Jiang G
    Environ Int; 2021 Nov; 156():106637. PubMed ID: 33993001
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Perfluoroalkyl substances and sex hormones in postmenopausal women: NHANES 2013-2016.
    Wang Y; Aimuzi R; Nian M; Zhang Y; Luo K; Zhang J
    Environ Int; 2021 Apr; 149():106408. PubMed ID: 33548847
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Perfluoroalkyl substances follow inverted U-shaped distributions across various stages of glomerular function: Implications for future research.
    Jain RB; Ducatman A
    Environ Res; 2019 Feb; 169():476-482. PubMed ID: 30530087
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Exposure to perfluoroalkyl substances (PFAS) and dyslipidemia, hypertension and obesity in adolescents. The Fit Futures study.
    Averina M; Brox J; Huber S; Furberg AS
    Environ Res; 2021 Apr; 195():110740. PubMed ID: 33460636
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of lifestyle-based lipid lowering interventions on the relationship between circulating levels of per-and polyfluoroalkyl substances and serum cholesterol.
    Morgan S; Mottaleb MA; Kraemer MP; Moser DK; Worley J; Morris AJ; Petriello MC
    Environ Toxicol Pharmacol; 2023 Mar; 98():104062. PubMed ID: 36621559
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Occupational exposure to perfluoroalkyl substances and serum levels of perfluorooctanesulfonic acid (PFOS) and perfluorooctanoic acid (PFOA) in an aging population from upstate New York: a retrospective cohort study.
    Tanner EM; Bloom MS; Wu Q; Kannan K; Yucel RM; Shrestha S; Fitzgerald EF
    Int Arch Occup Environ Health; 2018 Feb; 91(2):145-154. PubMed ID: 29027000
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Co-variate adjusted associations between serum concentrations of selected perfluoroalkyl substances and urinary concentrations of selected arsenic species.
    Jain RB
    Environ Sci Pollut Res Int; 2023 Mar; 30(12):34750-34759. PubMed ID: 36520294
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Determinants and Temporal Trends of Perfluoroalkyl Substances in Pregnant Women: The Hokkaido Study on Environment and Children's Health.
    Tsai MS; Miyashita C; Araki A; Itoh S; Bamai YA; Goudarzi H; Okada E; Kashino I; Matsuura H; Kishi R
    Int J Environ Res Public Health; 2018 May; 15(5):. PubMed ID: 29758015
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prenatal and postnatal exposure to PFAS and cardiometabolic factors and inflammation status in children from six European cohorts.
    Papadopoulou E; Stratakis N; Basagaña X; Brantsæter AL; Casas M; Fossati S; Gražulevičienė R; Småstuen Haug L; Heude B; Maitre L; McEachan RRC; Robinson O; Roumeliotaki T; Sabidó E; Borràs E; Urquiza J; Vafeiadi M; Zhao Y; Slama R; Wright J; Conti DV; Vrijheid M; Chatzi L
    Environ Int; 2021 Dec; 157():106853. PubMed ID: 34500361
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Associations between Per- and Polyfluoroalkyl Substances (PFAS) and Cardiometabolic Biomarkers in Adults of Czechia: The Kardiovize Study.
    Maranhao Neto GA; Polcrova AB; Pospisilova A; Blaha L; Klanova J; Bobak M; Gonzalez-Rivas JP
    Int J Environ Res Public Health; 2022 Oct; 19(21):. PubMed ID: 36360776
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Higher free thyroxine associated with PFAS exposure in first trimester. The Odense Child Cohort.
    Jensen RC; Glintborg D; Timmermann CAG; Nielsen F; Boye H; Madsen JB; Bilenberg N; Grandjean P; Jensen TK; Andersen MS
    Environ Res; 2022 Sep; 212(Pt D):113492. PubMed ID: 35597289
    [TBL] [Abstract][Full Text] [Related]  

  • 58. PFAS concentration during pregnancy in relation to cardiometabolic health and birth outcomes.
    Gardener H; Sun Q; Grandjean P
    Environ Res; 2021 Jan; 192():110287. PubMed ID: 33038367
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Exposure to perfluoroalkyl substances and thyroid function in pregnant women and children: A systematic review of epidemiologic studies.
    Ballesteros V; Costa O; Iñiguez C; Fletcher T; Ballester F; Lopez-Espinosa MJ
    Environ Int; 2017 Feb; 99():15-28. PubMed ID: 27884404
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Occurrence of legacy and alternative per- and polyfluoroalkyl substances in serum from high exposure population and their disrupting effects on serum lipids and thyroid function.
    Liu J; Song L; Zhan J; Zhong Y; Shi Z
    Sci Total Environ; 2023 Jun; 878():162988. PubMed ID: 36958558
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.